InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-12.7%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Clemens Jason A, Chief Financial Officer. Insider active across 1 company, notably AdaptHealth Corp.. In total, 16 filings have been published. Split: 3 buys · 1 sell. Total volume traded: €364k. History available since 11 October 2021. The latest transaction was filed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
126,899 shares0Common StockSEC:0001104659-26-009919:0
125,863 shares0Common StockSEC:0001104659-25-009134:0
35,000 shares@ US$9.3553.7% of flowCommon StockSEC:0001104659-24-128040:0
128,380 shares0Common StockSEC:0001104659-24-036718:0
139,112 shares0Common StockSEC:0001104659-24-011738:0
5,893 shares@ US$7.547.2% of flowCommon StockSEC:0001104659-23-109138:0
720 shares@ US$14.101.6% of flowCommon StockSEC:0001104659-23-091570:0
Ideal exit: 6 May 2024 (T+270)
5,972 shares@ US$12.8111.8% of flowCommon StockSEC:0001104659-23-081721:0
35,971 shares0Common StockSEC:0001104659-23-031879:0
624 shares@ US$15.991.6% of flowCommon StockSEC:0001104659-23-028024:0
3,606 shares@ US$21.3812.3% of flowCommon StockSEC:0001104659-23-010760:0
1,590 shares@ US$15.68990.0015% mcap33.1% of flowCommon StockSEC:0001104659-22-030059:0
Ideal exit: 27 Nov 2022 (T+270)
6,503 shares0Common StockSEC:0001104659-22-025200:0
37,670 shares0Common StockSEC:0001104659-22-011413:0
1,300 shares@ US$19.76680.0016% mcap33.5% of flowCommon StockSEC:0001104659-21-145997:0
Ideal exit: 28 Aug 2022 (T+270)
40,359 shares0Common StockSEC:0001104659-21-125923:0
16 of 16 declarations
About Clemens Jason A
Jason A. Clemens serves as the Chief Financial Officer at AdaptHealth Corp. He is responsible for managing the company's finances, including financial planning, risk management, and regulatory compliance. Jason plays a vital role in developing financial strategies that support AdaptHealth's growth and sustainability. His financial expertise is crucial for the company's success.
